China Shineway Pharmaceutical Group Limited (2877.HK) HKSE

9.11

-0.06(-0.65%)

Updated at November 14 02:57PM

Currency In HKD

Valuation

Market Cap6.86B
Enterprise Value1.07B
P/E Ratio7.68
PEG Ratio-4.26
Price/Sales Ratio1.89
Price/Book Ratio0.81
Enterprise/Revenue-0.06
Enterprise/EBITDA-0.23

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.25
Operating Margin0.19

Management Effectiveness

Return On Assets0.08
Return On Equity0.11

Income Statement

Revenue3.78B
Revenue/Share4.41
Gross Profit2.83B
EBITDA1B
Net Income840.05M
Diluted EPS1.11

Balance Sheet

Total Cash6.96B
Total Cash/Share9.04
Total Debt341.34M
Total Debt/Equity0.04
Current Ratio3.69
Book Value Per Share10.29

Price History

52-Week Change8.51
52-Week High10.76
52-Week Low6.96
Moving Average 50 Days8.56
Moving Average 200 Days8.19

Statistics

Average Volume1.42M
Shares Outstanding755.4M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.46
Trailing Annual Dividend Yield5.5
Payout Ratio0.43
Last Split FactorN/A
Last Split DateN/A